Finance

Lists
ARWR:NASDAQ
Arrowhead Pharmaceuticals Inc
$87.65
+2.12%
(+1.82) 1D
Aug 7, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARWR...
Open
$88.00
High
$88.67
Low
$86.48
Mkt. cap
12.38B
Avg. vol.
2.75M
Volume
5.00
52-wk high
$95.49
52-wk low
$15.01
EPS
-$2.15
Beta
1.27
Shares outstanding
141.25M
No. of employees
711
Open
$88.00
High
$88.67
Low
$86.48
Mkt. cap
12.38B
Avg. vol.
2.75M
Volume
5.00
52-wk high
$95.49
52-wk low
$15.01
EPS
-$2.15
Beta
1.27
Shares outstanding
141.25M
No. of employees
711
News stories
From sources across the web
Profile
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
About Arrowhead Pharmaceuticals Inc
CEOChristopher Richard Anzalone
Employees711
FoundedJan 1, 2004
HeadquartersPasadena, California, United States
SectorBiotechnology
Websitearrowheadpharma.com
Analyst ratings
Based on 11 analysts giving stock ratings to ARWR in the past 3 months
Strong buy
Buy
10
Hold
1
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for ARWR in the last 3 months.
Highest
Current $87.65
$126.00 (+43.75%)
Average
$103.96 (+18.61%)
Lowest
$46.00 (-47.52%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brian Cheng
J.P. Morgan
Buy
Maintained
$100.00
+14.1%
08/06/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
$120.00
+36.9%
08/07/2026
Michael Ulz
Morgan Stanley
Buy
Reiterated
$120.00
+36.9%
08/06/2026
Madison Elsaadi
B. Riley Securities
Buy
Reiterated
$123.00
+40.3%
08/05/2026
Luca Issi
RBC Capital
Buy
Maintained
$100.00
+14.1%
08/05/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
$126.00
+43.8%
08/05/2026
James Condulis
Stifel Nicolaus
Buy
Reiterated
$104.00
+18.7%
08/05/2026
Jason Gerberry
Bank of America Securities
Buy
Reiterated
$100.00
+14.1%
08/04/2026
Joseph Thome
TD Cowen
Buy
Reiterated
$89.59
+2.2%
08/04/2026
Keay Nakae
Chardan Capital
Buy
Maintained
$115.00
+31.2%
08/04/2026
William Pickering
Bernstein
Hold
Reiterated
$46.00
-47.5%
05/13/2026
Mani Foroohar
Leerink Partners
Hold
Maintained
-
-
03/26/2026
Last report
Aug 4, 2026
Fiscal period
Q3 2026
EPS / Est. (USD)
-$1.36 / -$1.23
-10.35%miss
Revenue / Est. (USD)
75.25M / 44.01M
+70.99%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
256.47M
264.03M
73.74M
75.25M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
181.07M
173.52M
165.66M
191.21M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
31.29M
49.70M
49.34M
54.14M
Operating expense
212.37M
223.22M
215.00M
245.35M
Total operating expenses
212.37M
223.22M
215.00M
245.35M
Operating income
44.11M
40.81M
-141.26M
-170.09M
Other non operating income
4.66M
277.00K
-1.61M
1.28M
EBT including unusual items
36.12M
28.27M
-137.56M
-178.90M
EBT excluding unusual items
36.12M
28.27M
-156.56M
-178.90M
Income tax expense
20.00M
29.00K
7.00K
11.00K
Effective tax rate
55.37%
0.10%
-0.01%
-0.01%
Other operating expenses
-
-
-
-
Net income
-23.75M
30.81M
-132.73M
-194.28M
Net profit margin
-9.26%
11.67%
-180.01%
-258.17%
Earnings per share
-0.18
0.22
-0.93
-1.36
Interest and investment income
9.05M
9.69M
16.87M
16.94M
Interest expense
-21.69M
-22.50M
-23.85M
-24.56M
Net interest expenses
-12.64M
-12.82M
-6.98M
-7.63M
Depreciation and amortization charges
-
-
-
-
EBITDA
50.49M
47.20M
-134.89M
-163.43M
Gain or loss from assets sale
-
-
-19.00M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps